Tag Archives: medicare
Drugs Approved Faster in US, Cost More
According to a study by the Tufts Center for the Study of Drug Development, more cancer drugs were approved in the US than in the EU during the 2010-2011 time … Continue reading
Posted in News
Also tagged cancer treatment, cost of care, insurance, outcomes, ovarian cancer, regulatory, Research, risk, treatment
Leave a comment
Update on Medicare Coverage for Avastin (bevacizumab)
Months ago, we told you about a Medicare contractor who was denying coverage of Avastin for patients with ovarian cancer. The Ovarian Cancer National Alliance has worked with Members of … Continue reading
Posted in Blog, News
Also tagged Avastin, cancer treatment, ovarian cancer, women's health
Leave a comment
